Publications by authors named "Yushi Murai"

Claim this Profile
D
Differential Transcriptomic Features of Peripheral Blood Mononuclear Cells in Pulmonary Sarcoidosis with and Without Extrapulmonary Lesions in an East Asian Population.
Yushi Murai, Takeshi Kawasaki, Takuro Imamoto, Daisuke Ishii, Keiichiro Yoshioka

Biomedicines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of giant amebic liver abscess persisting for years after treatment.
Rei Yasukochi, Hitoshi Kawasuji, Masayoshi Ezaki, Yusuke Takegoshi, Makito Kaneda, Yushi Murai

Int J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High feasibility of salivary therapeutic drug monitoring in linezolid, but lower feasibility in tedizolid: a single-dose study in healthy subjects and a monocentric prospective exploratory study in patients who received linezolid.
Hitoshi Kawasuji, Yasuhiro Tsuji, Keiko Miyaki, Takahiko Aoyama, Fumihiro Kurosaki, Yushi Murai

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Storage Conditions on Bronchoalveolar Lavage Fluid Analysis: A Human Study.
Yu Shionoya, Kanae Maruyama, Takeshi Kawasaki, Mayumi Ono, Yushi Murai

Diagnostics (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobinopathy as a Rare Differential Disease for Low Oxygen Saturation by Pulse Oximetry: A Case Report and Literature Review.
Kenichiro Takeda, Toshihiko Sugiura, Satoshi Isomatsu, Hidemi Ogawa, Yushi Murai

Intern Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: A multisite retrospective study.
Yushi Murai, Kentaro Nagaoka, Naoki Iwanaga, Hitoshi Kawasuji, Masayoshi Miura

Int J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study.
Kentaro Nagaoka, Naoki Iwanaga, Yushi Murai, Hitoshi Kawasuji, Masayoshi Miura

Infection· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant.
Yusuke Takegoshi, Kentaro Nagaoka, Toshiki Kido, Hitoshi Kawasuji, Yushi Murai

Ann Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Hiroshi Yamada, Yoshihiro Yoshida, Yushi Murai

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection.
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, Hideki Tani, Yoshihiro Yoshida, Yushi Murai

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of mycophenolate mofetil dosage to limit prolonged viral shedding in solid organ transplant recipients with COVID-19: Two case reports.
Yushi Murai, Seiichiro Sakao, Fujihiro Kure, Takeshi Kawasaki, Michihiro Maruyama

Respir Investig· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant Bacteremia: An 11-Year Retrospective Study in Japan.
Hitoshi Kawasuji, Yoshihiro Ikezawa, Mika Morita, Kazushige Sugie, Mayu Somekawa, Yushi Murai

Antibiotics (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants.
Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Bacteremia: A Systematic Review and Meta-Analysis.
Hitoshi Kawasuji, Kentaro Nagaoka, Yasuhiro Tsuji, Kou Kimoto, Yusuke Takegoshi, Yushi Murai

Antibiotics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study of Three Commercial Blood (1→3)-β-D-glucan Detection Reagents for Invasive Mycosis.
Yuki Miyajima, Kentaro Nagaoka, Yusuke Takegoshi, Makito Kaneda, Yushi Murai

Med Mycol J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Hiroshi Yamada, Yushi Murai

Microbiol Spectr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Makito Kaneda, Yushi Murai

J Infect Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection.
Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda

Viruses· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.
Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai, Makito Kaneda, Akitoshi Ueno

Front Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yoshihiro Yoshida, Yusuke Takegoshi, Yushi Murai

J Med Virol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Makito Kaneda, Yushi Murai

Microbiol Spectr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.
Yoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, Satoshi Nomura, Hitoshi Kawasuji, Yushi Murai

Microbiol Spectr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19.
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Miyuki Kimura, Hiroshi Yamada, Yushi Murai

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of nasopharyngeal viral load at discharge in patients with COVID-19.
Yasutaka Fukui, Hitoshi Kawasuji, Yusuke Taekgoshi, Makito Kaneda, Yushi Murai

J Infect Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.
Hitoshi Kawasuji, Yasuhiro Tsuji, Chika Ogami, Makito Kaneda, Yushi Murai

Antibiotics (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis